Sandoval Soraya O, Méndez-Albelo Natasha M, Xu Zhiyan, Zhao Xinyu
Waisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA.
J Neurodev Disord. 2024 Jun 13;16(1):30. doi: 10.1186/s11689-024-09545-w.
Fragile X syndrome (FXS) is caused by epigenetic silencing of the X-linked fragile X messenger ribonucleoprotein 1 (FMR1) gene located on chromosome Xq27.3, which leads to the loss of its protein product, fragile X messenger ribonucleoprotein (FMRP). It is the most prevalent inherited form of intellectual disability and the highest single genetic cause of autism. Since the discovery of the genetic basis of FXS, extensive studies using animal models and human pluripotent stem cells have unveiled the functions of FMRP and mechanisms underlying FXS. However, clinical trials have not yielded successful treatment. Here we review what we have learned from commonly used models for FXS, potential limitations of these models, and recommendations for future steps.
脆性X综合征(FXS)是由位于X染色体Xq27.3上的X连锁脆性X信使核糖核蛋白1(FMR1)基因的表观遗传沉默引起的,这导致其蛋白质产物脆性X信使核糖核蛋白(FMRP)缺失。它是最常见的遗传性智力残疾形式,也是自闭症的单一最高遗传病因。自发现FXS的遗传基础以来,使用动物模型和人类多能干细胞进行的广泛研究揭示了FMRP的功能以及FXS的潜在机制。然而,临床试验尚未产生成功的治疗方法。在此,我们回顾了从常用的FXS模型中学到的知识、这些模型的潜在局限性以及对未来研究方向的建议。